LEIBOWITZ GENERIC DRUGS

LEIBOWITZ GENERIC DRUGS

Andrew Harrer/Bloomberg

Jonathan Leibowitz, chairman of the U.S. Federal Trade Commission, said today he is "optimistic" Congress will pass legislation to stop drug companies from entering agreements that delay competition from generic drugs.